Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (CNY)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Biological Products

          

Pharmaceuticals

244M 481M 464M 407M 270M

Total Assets

2.27B 1.64B 1.66B 1.39B 1.36B

Interest Expense

-2.24M -8.48M -11.82M -15.17M -13.27M

Income Tax Expense

- - - - 13.06M

CAPEX

-149M -102M -15K - -

EBT

-1.92B -903M -367M -91.21M -424M

Gross Profit

137M 278M 304M 240M 51.25M

D&A

20.06M 42.03M 56.92M 49.74M 43.91M

Net Income

-1.92B -903M -367M -91.21M -437M
Geographical breakdown of sales (CNY)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Outside Mainland China

- - - 114M 186M

Total Assets

- - - 304M 245M

Mainland China

244M - - 293M 83.84M

France

- - 82.72M - -

- - - - 186M

Others

- 4.84M 10.89M - -

United States of America

- - - - -

PRC (Excluding Hong Kong and Taiwan)

- 477M 370M - -

Total Assets

2.27B 1.64B 1.66B - -

Interest Expense

- - - - -

D&A

- - - - -

CAPEX

- - - - -

Net Income

- - - - -

EBT

- - - - -

- - - - 83.84M